MindWalk Holdings (HYFT) Other Non Operating Income (2020 - 2026)
MindWalk Holdings (HYFT) reported Other Non Operating Income of -$197.44 for Q1 2026, up 99.74% year-over-year from -$98.85 in Q1 2025, and up 34.63% quarter-over-quarter from -$302.05 in Q4 2025.
MindWalk Holdings (HYFT) Other Non Operating Income (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Other Non Operating Income data on file, last reported at -$197.44 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$197.44, up 99.74% year-over-year; the trailing twelve-month figure through Jan 2026 was -$813.4 (up 99.97% YoY), and the FY2025 annual result was -$507.55, down 100.16% from the prior year.
- Other Non Operating Income advanced to -$197.44 in Q1 2026 per HYFT's latest filing, from -$302.05 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $163.3 million in Q3 2023 and troughed at -$2.9 million in Q3 2024.
- A 5-year average of $9.5 million and a median of -$197.44 in 2026 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income jumped 243189.94% in 2022, then plunged 678.24% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $261254.7 in 2022, then gained by 22.23% to $319334.9 in 2023, then plunged by 151.37% to -$164032.7 in 2024, then surged by 99.82% to -$302.05 in 2025, then soared by 34.63% to -$197.44 in 2026.
- Business Quant data shows HYFT's Other Non Operating Income at -$197.44 in Q1 2026, -$302.05 in Q4 2025, and -$14.56 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -197.44 |
| Oct 31, 2025 | -302.05 |
| Jul 31, 2025 | -14.56 |
| Apr 30, 2025 | -299.36 |
| Jan 31, 2025 | -74,669.25 |
| Oct 31, 2024 | -164,032.67 |
| Jul 31, 2024 | -2.92 Mn |
| Apr 30, 2024 | 65,639.30 |
| Jan 31, 2024 | -86,547.41 |
| Oct 31, 2023 | 319,334.85 |
| Jul 31, 2023 | 163.33 Mn |
| Apr 30, 2023 | 132,289.80 |
| Jan 31, 2023 | -11,120.92 |
| Oct 31, 2022 | 261,254.71 |
| Jul 31, 2022 | 329,671.50 |
| Apr 30, 2022 | -720,863.84 |
| Jan 31, 2022 | 544,366.25 |
| Oct 31, 2021 | 107.38 |
| Jul 31, 2021 | 11,395.76 |
| Apr 30, 2021 | 356,137.60 |